HONG KONG – (ACN Newswire) – Innovent Biologics [Innovent; HKG:1801], a China Suzhou-based biopharmaceutical company, completes its initial public offering in…
HONG KONG – (ACN Newswire) – Innovent Biologics [Innovent; HKG:1801], a China Suzhou-based biopharmaceutical company, completes its initial public offering in…